Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GLICLAZIDE vs GLOFITAMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GLICLAZIDE vs GLOFITAMAB: Safety Overview

Metric GLICLAZIDE GLOFITAMAB
Total FAERS Reports 5,784 1,116
Deaths Reported 483 315
Death Rate 8.4% 28.2%
Hospitalizations 3,195 492
Average Patient Age 65.0 yrs 62.5 yrs
% Female Patients 55.2% 53.2%
Manufacturer N/A Genentech, Inc.
Route N/A INTRAVENOUS